Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NK

NantKwest

$1.29

-0.05 (-3.73%)

16:12
08/23/19
08/23
16:12
08/23/19
16:12
Syndicate
Breaking Syndicate news story on NantKwest »

NantKwest files $300M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
NK

NantKwest

$1.09

-0.005 (-0.46%)

08:29
06/24/19
06/24
08:29
06/24/19
08:29
Hot Stocks
NantKwest launches Phase 1 PD-L1 t-haNK trial »

NantKwest announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
NK

NantKwest

$1.29

0.265 (25.85%)

08:07
06/04/19
06/04
08:07
06/04/19
08:07
Hot Stocks
NantKwest announces 'durable CR' after off-the-shelf aNK therapy »

Patrick Soon-Shiong, MD,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

NK

NantKwest

$1.29

0.265 (25.85%)

08:01
06/04/19
06/04
08:01
06/04/19
08:01
Hot Stocks
NantKwest partner presents updated nanatinostat data at ASCO »

NantKwest announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

NK

NantKwest

$1.13

0.105 (10.24%)

14:52
06/03/19
06/03
14:52
06/03/19
14:52
Hot Stocks
NantKwest launches Phase 1 trial of CD19 t-haNK cell therapy in lymphoma »

NantKwest announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

NK

NantKwest

$1.07

0.045 (4.39%)

07:37
05/31/19
05/31
07:37
05/31/19
07:37
Downgrade
NantKwest rating change at Citi »

Citi downgrades NantKwest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

NK

NantKwest

$1.07

0.045 (4.39%)

18:39
05/30/19
05/30
18:39
05/30/19
18:39
Downgrade
NantKwest rating change at Citi »

NantKwest downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

NK

NantKwest

$1.13

0.02 (1.80%)

08:11
05/01/19
05/01
08:11
05/01/19
08:11
Hot Stocks
Brink Biologics, WPI announce research license agreement for NK-92 cells »

Brink Biologics, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$1.58

-0.12 (-7.06%)

08:18
04/01/19
04/01
08:18
04/01/19
08:18
Hot Stocks
NantKwest issued EU patent for 'Genetically Modified Human Natural Killer Cell' »

NantKwest announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$1.36

0.01 (0.74%)

, MKGAY

Merck KGaA

$0.00

(0.00%)

08:08
01/09/19
01/09
08:08
01/09/19
08:08
Hot Stocks
NantKwest announces launch of MCC Phase II trial »

NantKwest (NK) announced…

NK

NantKwest

$1.36

0.01 (0.74%)

MKGAY

Merck KGaA

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.